ArticleArchives of pharmacal research2023

Engineered fibrotic liver-targeted truncated transforming growth factor β receptor type II variant for superior anti-liver fibrosis therapy.

Manman Ma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.